Pfizer faces criticism for arguing that intellectual property for its Covid-19 pill is a human right

April 21, 2022 |
Covid Booster Costs Spur Calls to Shift From Free Jabs for All
A compromise on patent waivers for Covid-19 vaccines takes a key step at the WTO
Related Posts
Access to Medicines

Pharma’s alleged “brea...
PEPFAR Watch

PEPFAR is Rolling the Cloc...
Access to Medicines

Pharma Pricing Secrecy Run...